利用多模式神经成像和GWAS来识别阿尔茨海默病的模式级因果途径
Yuan Tian1, Daniel Felsky2,3,4,5, Jessica Gronsbell1,6,7
1Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
Imaging neuroscience (Cambridge, Mass.)
|August 13, 2025
概括
这项研究引入了一种新的方法来识别基因和脑成像特征之间的因果关系,通过控制混因素来改善我们对脑部疾病的理解. 这种方法增强了对神经疾病的遗传和成像生物标志物的发现.
科学领域:
- 神经成像遗传学 神经成像遗传学
- 生物标志物发现发现
- 因果推理因果推理
背景情况:
- 英国生物银行为超过4万个个体提供了广泛的脑成像衍生的表型 (IDP) 和遗传数据.
- 在成像遗传学中,现有的仪器变量 (IV) 方法面临着诸如水平形和高维度等挑战.
- 将基因表达与全基因组关联研究 (GWAS) 整合起来,对于理解对大脑疾病的遗传影响至关重要.
研究的目的:
- 提出和验证一种用于测试个体基因和特定脑成像模式之间的因果关系的新方法.
- 为了解决当前成像遗传学方法的方法限制,特别是横向类.
- 增强对遗传变异在脑结构,功能和扩散MRI中的作用及其对行为的影响的理解.
主要方法:
- 开发了一个因果关系测试框架,专注于个体大脑模式 (结构,功能,扩散MRI) 和基因.
- 实施了一种方法,以控制不同成像模式的IDP的类效应.
- 利用阿尔茨海默氏症GWAS数据 (英国生物银行和IGAP) 的总结统计数据进行方法验证.
主要成果:
- 拟议的方法有效地测试每个基因的大脑模式的因果关系,为现有的IV方法提供了替代方案.
- 证明了该方法在识别对与阿尔茨海默病相关的大脑成像表型的遗传影响方面的实用性.
- 该方法提供了对遗传变异和脑成像特征之间的相互作用的更深入的见解.
结论:
- 新的因果关系测试框架为成像遗传学研究提供了一个强大的替代方案.
- 这种方法通过控制性质来促进对脑部疾病遗传贡献的更细致的理解.
- 该方法是使用易于获取的总结统计数据来实现的,并且可以在GitHub上访问.
更多相关视频
相关概念视频
01:26Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
01:22Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
01:11Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K